Moreover, we further verified that Spry2, as a direct target of miR-21, could mediated the effects of miR-21 on pancreatic cancer cell proliferation by inhibiting MAPK/ERK and PI3K/AKT signal pathway. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.